The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder
Abstract
Nine of 17 patients with obsessive-compulsive disorder responded when neuroleptic was added to fluvoxamine with or without lithium. Comorbid occurrence of tic spectrum disorders or of schizotypal personality disorder was associated with response. Abnormalities in brain dopamine and serotonin may be implicated in such patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Pauls, D. L. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800120066013 · Cited by 575
Shapiro, E. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810080052006 · Cited by 355
Concomitant obsessive-compulsive disorder and schizotypal personality disorder
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.4.530 · Cited by 174
Behavioral aspects of serotonin-dopamine interaction in the monkey
Korsgaard, S., Gerlach, J., & Christensson, E. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90135-9 · Cited by 146
Reliability and Validity of the Symptoms of Major Depressive Illness
Mazure, C. M. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800050053006 · Cited by 103
Cited by
A family study of obsessive–compulsive disorder
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.1.76 · Cited by 1,022
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder
Saxena, S., & Rauch, S. L. (2000) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70181-7 · Cited by 840
Neuroimaging and frontal–subcortical circuitry in obsessive–compulsive disorder
Saxena, S., Brody, A. L., Schwartz, J. M., & Baxter, L. R. (1998) · British Journal of Psychiatry · doi:10.1192/s0007125000297870 · Cited by 831
Bilder, R. M., Volavka, J., Lachman, H. M., & Grace, A. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300542 · Cited by 769
Bloch, M. H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V, Bracken, M. B., & Leckman, J. F. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001823 · Cited by 635
McDougle, C. J., Epperson, C. N., Pelton, G. H., Wasylink, S., & Price, L. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.794 · Cited by 571
Self-citationMcDougle, C. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040046006 · Cited by 570
Greist, J. H. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950130053006 · Cited by 500
The Epidemiology and Differential Diagnosis of Obsessive-Compulsive Disorder
Rasmussen, S. A., & Eisen, J. L. (1992) · Zwangsstörungen / Obsessive-Compulsive Disorders · doi:10.1007/978-3-642-77608-3_1 · Cited by 493
Stein, D. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09620-4 · Cited by 352
Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?
Phillips, K. A., Stein, D. J., Rauch, S. L., Hollander, E., Fallon, B. A., Barsky, A., Fineberg, N., Mataix-Cols, D., Ferrão, Y. A., Saxena, S., et al. (2010) · Depression and Anxiety · doi:10.1002/da.20705 · Cited by 347
Evidence-based pharmacotherapy of obsessive-compulsive disorder
Fineberg, N. A., Brown, A., Reghunandanan, S., & Pampaloni, I. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001829 · Cited by 336
Obsessive-compulsive disorder phenotypes: implications for genetic studies
Miguel, E. C., Leckman, J. F., Rauch, S., do Rosario-Campos, M. C., Hounie, A. G., Mercadante, M. T., Chacon, P., & Pauls, D. L. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001617 · Cited by 282
(2004) · PubMed · Cited by 279
Sensory Phenomena in Obsessive-Compulsive Disorder and Tic Disorders:A Review of the Literature
Prado, H. D. S., Rosário, M. C. D., Lee, J., Hounie, A. G., Shavitt, R. G., & Miguel, E. C. (2008) · CNS Spectrums · doi:10.1017/s1092852900016606 · Cited by 186
Leckman, J. F., Goodman, W. K., Anderson, G. M., Riddle, M. A., Chappell, P. B., McSwiggan-Hardin, M. T., McDougle, C. J., Scahill, L. D., Ort, S. I., Pauls, D. L., et al. (1995) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380241 · Cited by 169
Self-citationCurrent animal models of obsessive compulsive disorder: a critical review
Joel, D. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.006 · Cited by 168
Neurobiology of Obsessive-Compulsive Disorder:Serotonin and Beyond
Westenberg, H. G. M., Fineberg, N. A., & Denys, D. (2007) · CNS Spectrums · doi:10.1017/s1092852900002479 · Cited by 148
Heterogeneity of obsessive-compulsive disorder: A literature review
Lochner, C., & Stein, D. J. (2003) · Harvard Review of Psychiatry · doi:10.1080/10673220303949 · Cited by 143
Pharmacotherapy of obsessive–compulsive disorder: evidence-based treatment and beyond
Fineberg, N. A., Reghunandanan, S., Brown, A., & Pampaloni, I. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412461958 · Cited by 122
“McDougle et al. (1990) reported benefit from adding openlabel pimozide (6.5 mg) in 17 patients unresponsive to fluvoxamine.”
BackgroundInfluentialMuscatello, M. R. A., Bruno, A., Pandolfo, G., Micò, U., Scimeca, G., Romeo, V. M., Santoro, V., Settineri, S., Spina, E., & Zoccali, R. A. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31820e3db6 · Cited by 122
Item-by-Item Factor Analysis of the Yale-Brown Obsessive Compulsive Scale Symptom Checklist
Feinstein, S. B., Fallon, B. A., Petkova, E., & Liebowitz, M. R. (2003) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.15.2.187 · Cited by 122
Fineberg, N. A., Stein, D. J., Premkumar, P., Carey, P., Sivakumaran, T., Vythilingum, B., Seedat, S., Westenberg, H., & Denys, D. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000215083.57801.11 · Cited by 103
Neuropsychological predictors of response to randomized treatment in obsessive–compulsive disorder
D'Alcante, C. C., Diniz, J. B., Fossaluza, V., Batistuzzo, M. C., Lopes, A. C., Shavitt, R. G., Deckersbach, T., Malloy-Diniz, L., Miguel, E. C., & Hoexter, M. Q. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.07.002 · Cited by 98
Albert, U., Marazziti, D., Di Salvo, G., Solia, F., Rosso, G., & Maina, G. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867325666171222163645 · Cited by 90
Kim, C.-H., Koo, M.-S., Cheon, K.-A., Ryu, Y.-H., Lee, J.-D., & Lee, H.-S. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1245-7 · Cited by 82
Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms?
Sareen, J., Kirshner, A., Lander, M., Kjernisted, K. D., Eleff, M. K., & Reiss, J. P. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.03.011 · Cited by 79
Bokor, G., & Anderson, P. D. (2014) · Journal of Pharmacy Practice · doi:10.1177/0897190014521996 · Cited by 79
Review of interventions for the management of anxiety symptoms in children with ASD
Delli, C. K. S., Polychronopoulou, S. A., Kolaitis, G. A., & Antoniou, A. S. G. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.10.023 · Cited by 30
Ruiz (2000) · doi:10.1097/00131746-200005000-00002 · Cited by 14
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1990-05-01
- Volume
- 147
- Issue
- 5
- Pages
- 652-654
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W120466105
- Cited by
- 271
- References
- 6
- FWCI
- 14.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.